Cancer vaccines
Researchers from the University of Gothenburg conducted a prospective observational study to investigate the humoral and cellular immune responses to COVID-19 vaccination in patients with non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitor (ICI) therapy. The study found that patients on ICI therapy exhibited lower and more variable IgG
Cancer treatment
Researchers at the Department of Pharmaceutical Technology have discovered that mRNA-based vaccines can revolutionize cancer treatment in melanoma therapy. According to the study, published in Advances in Immunology, the mRNA-4157/V940 cancer vaccine encodes 34 patient-specific tumor euroantigens, instructing the immune system to distinguish healthy and malignant cells. The vaccine
Cancer treatment
mRNA cancer vaccines, leveraging technology from the COVID-19 pandemic, are rapidly evolving and have the potential to redefine oncology standards of care with targeted immunotherapy. Over 60 mRNA cancer vaccine candidates are currently under development, with a few already in mid- and late-stage clinical trials. These vaccines function by teaching
Cancer patients
During the COVID-19 pandemic, Mexico utilized seven different vaccine platforms, but prioritization for oncologic patients was lacking. Researchers from the Instituto Nacional de Cancerologia in Mexico City studied the outcomes of SARS-CoV-2 infections in cancer patients after the national vaccine campaign began. The study included 691 patients with cancer and
Cancer vaccines
Researchers from Dalian Medical University in Liaoning, People's Republic of China, have published a review on the functions of RNA modifications and their application in mRNA cancer vaccines. The study highlights recent advances in mRNA cancer immunotherapy and provides perspectives for future development of mRNA vaccines in personalized
Cancer vaccines
Dr. Xiangrong Song, co-founder of WestGene Biopharma, presented her pioneering work in the field of mRNA therapeutics, particularly with regard to the world-leading EBV-targeted therapeutic mRNA vaccine against cancer, WGc-043, at the 4th mRNA Therapeutics Summit in Boston. The summit, attended by over 400 industry experts and 65 leading researchers,
Cancer vaccines
The 4th mRNA Therapeutics Summit, held in Boston from July 29-31, 2024, brought together over 400 industry experts and 65 leading researchers to discuss the latest advancements in mRNA technology. Dr. Xiangrong Song, co-founder of WestGene Biopharma, presented key findings on the world's leading EBV-related cancer mRNA therapeutic
